학술논문
P683: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES (TRIAL IN PROGRESS)
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 579-580 (2022)
Subject
Language
English
ISSN
2572-9241